- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02343965
The Impact of the Practice of Touch-massage on the Anxiety of Patients With Hematological Disorders Hospitalized in a Protective Environment, a Randomized, Controlled Study (TANDHEMS)
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with hematologic diseases (leukaemia, Myeloma, lymphoma) hospitalized in a sterile area of a hematology unit for at least 3 weeks
- 18 to 65 years
- Female or male
- Not having met the nurse, who is providing the touch-massage
Exclusion Criteria:
- Allergy to sweet almond oil
- Injury to the skin, at the back and / or arms and / or hands
- Cognitive impairment and / or preventing psychiatric responses to interviews and / or questionnaires
- Physical inability to take sitting in an ergonomic chair for the conduct of touch massage.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Touch-massage group
Patient receive 3 sessions of touch-massage (the duration of a session of touch massage is 15 minutes) ,once a week, for 3 weeks
|
|
No Intervention: without touch-massage group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Impact of touch-massage practice on patients' anxiety state, as measured by the anxiety-state questionnaire (Spielberger, CD et al, 1983) to assess the predisposition to anxiety.
Time Frame: 3 weeks
|
Each patient will complete the anxiety-state questionnaire (Spielberger, CD et al, 1983) to assess the predisposition to anxiety. The evolution of patient anxiety is calculated from the six scores of the anxiety-state scale administered before and after each of the 3 sessions of touch-massageusing the trait anxiety scale score. |
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evolution of Self Esteem, as measured by the self-esteem questionnaire
Time Frame: 3 weeks
|
Each patient will complete the self-esteem questionnaire before the first and after the final session of touch-massage .
|
3 weeks
|
Evolution of anxiety, measured by the the anxiety-state questionnaire (Spielberger, CD et al, 1983)
Time Frame: 3 weeks
|
Each patient will complete the anxiety-state questionnaire (Spielberger, CD et al, 1983) to assess the predisposition to anxiety. The evolution of patient anxiety is calculated from the six scores of the anxiety-state scale administered before and after each of the 3 sessions of touch-massageusing the trait anxiety scale score. |
3 weeks
|
Evolution of anxiety
Time Frame: 3 weeks
|
Quantitative Analysis about 2 interviews recorded.In order to complement and enrich the quantitative data, two interviews will be conducted with patients receiving send the touch-massage.
The data collected will be subjected to a thematic content analysis.
|
3 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC14_0202
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hematologic Diseases
-
St. Jude Children's Research HospitalRecruitingRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
University of Colorado, DenverNot yet recruitingHematologic Malignancy | Pediatric Patients | Other Hematologic ConditionUnited States
-
Epizyme, Inc.WithdrawnRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingHematologic MalignancyChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Massachusetts General HospitalRecruiting
-
Fondazione EMN Italy OnlusCompletedHEMATOLOGIC MALIGNANCIESItaly
-
Center for International Blood and Marrow Transplant...National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompletedHematologic MalignancyUnited States
-
Rigshospitalet, DenmarkNovo Nordisk A/SCompletedHematologic MalignancyDenmark
-
SecuraBioCompletedHematologic MalignancyUnited States, Italy
Clinical Trials on Touch-massage
-
Versailles HospitalCompleted
-
University of FloridaCompletedMusculoskeletal Pain | Neck PainUnited States
-
MetroHealth Medical CenterRecruitingBreast Cancer | Mobility Limitation | Mastectomy; Lymphedema | Pain, ShoulderUnited States
-
Umeå UniversityTerminated
-
Emory UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedGeneralized Anxiety DisorderUnited States
-
University of Maryland, BaltimoreRecruiting
-
Yuzuncu Yıl UniversityIstanbul University - Cerrahpasa (IUC)Recruiting
-
Emory UniversityNational Cancer Institute (NCI); National Center for Complementary and Integrative...CompletedCancer Related FatigueUnited States
-
Fanny AirosaKarolinska InstitutetCompleted
-
Emory UniversityCompletedCancer-related Problem/ConditionUnited States